RightFit Trial Directory

Breast Cancer clinical trials in Torrance, CA

10 recruiting breast cancer studies with a site in Torrance, CA.

All trials in Torrance, CA · All Breast Cancer trials

RecruitingPhase 3NCT06492616

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

Sponsor: Stemline Therapeutics, Inc.

Bakersfield, CA · Berkeley, CA · Beverly Hills, CA · +173 more sites

RecruitingPhase 3NCT05879926

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Sponsor: NRG Oncology

Anaheim, CA · Antioch, CA · Arroyo Grande, CA · +1223 more sites

RecruitingPhase 3NCT06072612

Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.

Sponsor: BriaCell Therapeutics Corporation

Anaheim, CA · Bakersfield, CA · Beverly Hills, CA · +76 more sites

RecruitingPhase 3NCT05812807

Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab

Sponsor: Alliance for Clinical Trials in Oncology

Arroyo Grande, CA · Berkeley, CA · +825 more sites

RecruitingEarly Phase 1NCT06123286

Tart Cherry and Omega-3's for Aromatase Inhibitor Musculoskeletal Symptoms

Sponsor: Philip Chang

Los Angeles, CA · Torrance, CA

RecruitingPhase 2NCT07017673

Phase II Trial of Ivonescimab in Combination With Carboplatin + Docetaxel in Patients With Early-Stage Triple Negative Breast Cancer

Sponsor: Cedars-Sinai Medical Center

Los Angeles, CA · Pasadena, CA · +1 more sites

RecruitingPhase 1NCT04389632

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

Sponsor: Seagen, a wholly owned subsidiary of Pfizer

Anaheim, CA · Fullerton, CA · +103 more sites

RecruitingPhase 3NCT04852887

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

Sponsor: NRG Oncology

Anaheim, CA · Antioch, CA · Arroyo Grande, CA · +809 more sites

RecruitingPhase 2NCT04553770

Trastuzumab Deruxtecan Alone or in Combination With Anastrozole for the Treatment of Early Stage HER2 Low, Hormone Receptor Positive Breast Cancer

Sponsor: Jonsson Comprehensive Cancer Center

Fullerton, CA · Los Alamitos, CA · Los Angeles, CA · +6 more sites

RecruitingPhase 3NCT05929768

Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer

Sponsor: SWOG Cancer Research Network

Anaheim, CA · Arroyo Grande, CA · +952 more sites

Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.